Artivion, Inc. (AORT) Stock Analysis
Falling Knife setup
Healthcare · Medical Devices
Hold if already holding. Not a fresh buy at $22.34, but acceptable to hold if already in. Reasons: Concentration risk — Supplier: Endospan; Concentration risk — Supplier: AMDS sole manufacturer.
Artivion manufactures and distributes medical devices and implantable human tissues for cardiac and vascular surgical procedures across four product families: aortic stent grafts, On-X mechanical heart valves, BioGlue surgical sealant, and preservation services. Revenue comes... Read more
Hold if already holding. Not a fresh buy at $22.34, but acceptable to hold if already in. Reasons: Concentration risk — Supplier: Endospan; Concentration risk — Supplier: AMDS sole manufacturer. Chart setup: Death cross, below all MAs, RSI 21, MACD bearish. Mixed signals. Hold existing position. Score 5.6/10, moderate confidence.
Passes 7/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 79d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: aggressive.
Recent Developments — Artivion, Inc.
Latest news
- What To Expect From Artivion’s (AORT) Q1 Earnings - StockStory — StockStory neutral
- What To Expect From Artivion’s (AORT) Q1 Earnings - FinancialContent — FinancialContent neutral
- Conestoga Capital Adds Artivion to Portfolio Amid Market Volatility - HarianBasis.co — HarianBasis.co positive
- Strong Catalysts Drive Artivion (AORT) - Insider Monkey — Insider Monkey positive
- Strong Catalysts Drive Artivion (AORT) - Yahoo Finance — Yahoo Finance positive
Generated 2026-05-20T21:06:21Z.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHSupplierEndospan10-K Item 1A: 'the NEXUS family of products are solely manufactured by Endospan in Herzliya, Israel.'
- HIGHSupplierAMDS sole manufacturer10-K Item 1A: 'The AMDS product is solely manufactured by a supplier in Charlotte, North Carolina'
- HIGHProductBioGlue10-K Item 1A: 'BioGlue is a significant source of our revenues, and as such, any risk adversely affecting our BioGlue products or business would likely be material to our financial results.'
- HIGHProductaortic stent grafts10-K Item 1A: 'Aortic stent grafts are a significant source of our revenues, and as such, any risk adversely affecting aortic stent grafts would likely be material to our financial results.'
- HIGHProductOn-X products10-K Item 1A: 'On-X products are a significant source of our revenues, and as such, any risk adversely affecting our On-X products or business would likely be material to our financial results.'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
2 floor-breakers
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $22.34, but acceptable to hold if already in. Reasons: Concentration risk — Supplier: Endospan; Concentration risk — Supplier: AMDS sole manufacturer. Chart setup: Death cross, below all MAs, RSI 21, MACD bearish. Mixed signals. Hold existing position. Target $37.30 (+67.0%), stop $21.14 (−5.7%), A.R:R 4.3:1. Score 5.6/10, moderate confidence.
Take-profit target: $37.30 (+64.1% upside). Target $37.30 (+67.0%), stop $21.14 (−5.7%), A.R:R 4.3:1. Stop-loss: $21.14.
Concentration risk — Supplier: Endospan; Concentration risk — Supplier: AMDS sole manufacturer; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.6).
Artivion, Inc. trades at a P/E of 95.0 (forward 29.5). TrendMatrix value score: 5.8/10. Verdict: Hold.
13 analysts cover AORT with a consensus score of 4.3/5. Average price target: $43.
What does Artivion, Inc. do?Artivion manufactures and distributes medical devices and implantable human tissues for cardiac and vascular surgical...
Artivion manufactures and distributes medical devices and implantable human tissues for cardiac and vascular surgical procedures across four product families: aortic stent grafts, On-X mechanical heart valves, BioGlue surgical sealant, and preservation services. Revenue comes from Medical Devices and Preservation Services segments sold globally, with BioGlue, aortic stent grafts, and On-X each described as significant revenue sources.